Evidence map›Paper›PMID 24409052›Full record

ReviewWorld journal of gastroenterology2013

Pathophysiology of cerebral oedema in acute liver failure.

Teresa R Scott, Victoria T Kronsten, Robin D Hughes, Debbie L Shawcross

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 126 citations in OpenAlex.

  1. The role of ammonia in chronic liver disease.Hepatology communications · 2026
    Review
  2. Article
  3. Continuous renal replacement therapy in acute liver failure.World journal of critical care medicine · 2026
    Review
  4. Observational
  5. Article
  6. Oedematic-atrophic astrocytes in hepatic encephalopathy.Acta neuropathologica communications · 2025
    Article
  7. Article
  8. Article
  9. Brain health: A concern for anaesthesiologists and intensivists.European journal of anaesthesiology and intensive care · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Teresa R ScottTeresa R Scott, Victoria T Kronsten, Robin D Hughes, Debbie L Shawcross, Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, King's College Hospital, London SE5 9RS, United Kingdom.
Victoria T KronstenTeresa R Scott, Victoria T Kronsten, Robin D Hughes, Debbie L Shawcross, Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, King's College Hospital, London SE5 9RS, United Kingdom.
Robin D HughesTeresa R Scott, Victoria T Kronsten, Robin D Hughes, Debbie L Shawcross, Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, King's College Hospital, London SE5 9RS, United Kingdom.
Debbie L ShawcrossTeresa R Scott, Victoria T Kronsten, Robin D Hughes, Debbie L Shawcross, Institute of Liver Studies, King's College London School of Medicine at King's College Hospital, King's College Hospital, London SE5 9RS, United Kingdom.
King's College Hospital · GB

Funding

Medical Research Council MR/J006742/1
6 · The paper itself

Abstract

Cerebral oedema is a devastating consequence of acute liver failure (ALF) and may be associated with the development of intracranial hypertension and death. In ALF, some patients may develop cerebral oedema and increased intracranial pressure but progression to life-threatening intracranial hypertension is less frequent than previously described, complicating less than one third of cases who have proceeded to coma since the advent of improved clinical care. The rapid onset of encephalopathy may be dramatic with the development of asterixis, delirium, seizures and coma. Cytotoxic and vasogenic oedema mechanisms have been implicated with a preponderance of experimental data favouring a cytotoxic mechanism. Astrocyte swelling is the most consistent neuropathological finding in humans with ALF and ammonia plays a definitive role in the development of cytotoxic brain oedema. The mechanism(s) by which ammonia induces astrocyte swelling remains unclear but glutamine accumulation within astrocytes has led to the osmolyte hypothesis. Current evidence also supports an alternate 'Trojan horse' hypothesis, with glutamine as a carrier of ammonia into mitochondria, where its accumulation results in oxidative stress, energy failure and ultimately astrocyte swelling. Although a complete breakdown of the blood-brain barrier is not evident in human ALF, increased permeation to water and other small molecules such as ammonia has been demonstrated resulting from subtle alterations in the protein composition of paracellular tight junctions. At present, there is no fully efficacious therapy for cerebral oedema other than liver transplantation and this reflects our incomplete knowledge of the precise mechanisms underlying this process which remain largely unknown.

Indexed as

AmmoniaAnimalsAstrocytesBlood-Brain BarrierBrainBrain EdemaCapillary PermeabilityDisease ProgressionEnergy MetabolismGlutamic AcidHepatic EncephalopathyHumansLiver Failure, AcuteMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreAmmoniaGlutamic AcidMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreAcute liver failureAmmoniaCerebral blood flowCerebral oedemaHepatic encephalopathyIntracranial hypertensionIntracranial pressure

Identifiers

PMID24409052
PMCPMC3882398
OpenAlexW2011416235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.